Patents by Inventor Simone HOERTNER

Simone HOERTNER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Targeting aminoacid lipids
    Patent number: 11510988
    Abstract: The present invention is directed to carrier systems comprising ether-lipids conjugated to one or more bioactive ligands and exposed on the surface of the carrier system for use in targeted delivery and/or antigen display systems. Optionally one or more further bioactive agents may be encapsulated or embedded within or attached to or adsorbed onto the carrier system. The present invention is further directed to methods of their preparation and their uses in medical applications, such as targeted delivery of bioactive agents to specific tissues or cells and antigen display systems for the study, diagnosis, and treatment of traits, diseases and conditions that respond to said bioactive agents.
    Type: Grant
    Filed: January 11, 2018
    Date of Patent: November 29, 2022
    Assignee: Merck Patent GmbH
    Inventors: Michael Platscher, Raymond Behrendt, Viola Groehn, Simone Hoertner, Marco Passafaro, Finn Bauer
  • TARGETING AMINOACID LIPIDS
    Publication number: 20180133334
    Abstract: The present invention is directed to carrier systems comprising ether-lipids conjugated to one or more bioactive ligands and exposed on the surface of the carrier system for use in targeted delivery and/or antigen display systems. Optionally one or more further bioactive agents may be encapsulated or embedded within or attached to or adsorbed onto the carrier system. The present invention is further directed to methods of their preparation and their uses in medical applications, such as targeted delivery of bioactive agents to specific tissues or cells and antigen display systems for the study, diagnosis, and treatment of traits, diseases and conditions that respond to said bioactive agents.
    Type: Application
    Filed: January 11, 2018
    Publication date: May 17, 2018
    Applicant: Merck Patent GmbH
    Inventors: Michael PLATSCHER, Raymond BEHRENDT, Viola GROEHN, Simone HOERTNER, Marco PASSAFARO, Finn BAUER